SLRX icon

Salarius Pharmaceuticals
SLRX

Overview Fund Trends Analyst Outlook Journalist POV

29 hedge funds and large institutions have $10.2M invested in Salarius Pharmaceuticals in 2021 Q2 according to their latest regulatory filings, with 6 funds opening new positions, 7 increasing their positions, 9 reducing their positions, and 7 closing their positions.

New
Increased
Maintained
Reduced
Closed

less ownership

Funds ownership: →

less funds holding

Funds holding: →

less first-time investments, than exits

New positions opened: | Existing positions closed:

less repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

55% less capital invested

Capital invested by funds: $22.8M → $10.2M (-$12.6M)

Holders
29
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
–
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
–
Puts
–
Net Calls
Net Calls Change

Top Buyers

1
+$518K
2
+$162K
3
+$151K
4
BlackRock
BlackRock
New York
+$142K
5
Vanguard Group
Vanguard Group
Pennsylvania
+$130K

Top Sellers

1
-$1.88M
2
-$1.85M
3
-$1.04M
4
MS
Maven Securities
Jersey
-$633K
5
Renaissance Technologies
Renaissance Technologies
New York
-$352K
Name Holding Trade Value Shares
Change 		Change in
Stake
26
$22K
27
$12K
28
$7K
29
$500
30
–
31
–
32
–
33
–
34
–
35
–
36
–
1
2